Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 3330

Journal of Biotechnology & Biomaterials received 3330 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Regulatory hurdles of gene editing, how to overcome them

Joint Event on 22nd Global Congress on Biotechnology & 5th International Conference on Enzymology and Protein Chemistry

Klaus Ammann

University of Bern, Switzerland

Keynote: J Biotechnol Biomater

DOI: 10.4172/2155-952X-C2-114

Abstract
Gene editing is a new plant breeding method of precise elegance. It will be a unique chance to create new crops, adapted to climate change, be more productive and building new sustainable resistance against the steadily growing and adapting crop pests. It will also help to shift modern agriculture to a more ecological production, in short: it is the future of modern agriculture. Opposition against the new breeding methods is often based on fundamentalist arguments which are not really built on science. Anti-GM literature is often full of questionable statistics and fake arguments. This is a great pity, since stigmatization of the new gene editing is unfortunately built on the easy going psychology of fear of fake risks, often welcomed by a society in rich countries, where the population desperately longs for new risk fights in a clearly growing safety of personal life. It would be much better to develop a constructive attitude, which could manifest in organo-transgenic agricultural strategies, where the best sides of organic farming and modern breeding built on gene editing could be combined without the ideological and commercial hurdles.
Biography

Klaus Ammann, Emeritus Prof. Hon. from the Bern University, Switzerland. Prof. Emeritus Hon. Bern University Switzerland. Thesis: vegetation and glacier history, summa cum laude in 1972 Bern University. Research topics: Biodiversity, Vegetation Ecology, Lichens and Mosses, Biomonitoring of Air Pollution, Plant Biotechnology: Biosafety, Gene Flow and Ecology of Transgenic Crops. Guest lecturing in Delft, Netherlands, Istanbul, Turkey, research in Jamaica, at Duke University and Missouri Botanical Garden. Member of the steering committee of www.prri.net. Scientific activities: maintaining 650 endnote reference bibliographies on plant biotechnology and biodiversity, over 320 publications under Klaus Ammann in journals, blogs, newspapers, books on biosafety research and ca. 210 slide presentations, many literature references with full text links. Editor, Co-Editor in journals from Elsevier, Springer and Landes. Member of scientific committees in Switzerland and Europe on biodiversity and biosafety. Fellow of the Royal Society of Biology, external member of the European Academy.

E-mail: klaus.ammann@ips.unibe.ch

 

Top